Christensen Jamie
EVP & Chief Scientific Officer at Mirati Therapeutics, Inc.
- Sold, on record
- $6.2M
- Dollars the filings state
- Form 4 sales
- 29
- Latest Jan 16, 2024
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Mirati Therapeutics, Inc.EVP & Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Mirati Therapeutics, Inc.Plan not statedDec 16, 2022 2022
Sold 2,410 shares at $43.00 ($104k)
Christensen Jamie, EVP, Chief Scientific Officer
Sold 2.3% of holdings ($4.5M position)102,072 shares left2x usual sizeFiling
- 2 Form 4 sale Mirati Therapeutics, Inc.Plan not statedJan 4, 2023 +19 days
Sold 1,949 shares at $46.60 ($91k)
Christensen Jamie, EVP, Chief Scientific Officer
Sold 1.9% of holdings ($4.8M position)100,123 shares left1.5x usual sizeFiling
- 3 Form 4 sale Mirati Therapeutics, Inc.Plan not statedJan 17, 2023 +13 days
Sold 2,245 shares at $42.38 ($95k)
Christensen Jamie, EVP, Chief Scientific Officer
Sold 2.2% of holdings ($4.2M position)97,878 shares left1.7x usual sizeFiling
- 4 Form 4 sale Mirati Therapeutics, Inc.No planMay 24, 2023 +127 days
Sold 619 shares at $45.29 ($28k)
Christensen Jamie, EVP & Chief Scientific Officer
No 10b5-1 planSold 0.5% of holdings ($5.6M position)124,123 shares left0.4x usual sizeFiling
- 5 Form 4 sale Mirati Therapeutics, Inc.No planSep 8, 2023 +107 days
Sold 2,388 shares at $35.63 ($85k)
Christensen Jamie, EVP & Chief Scientific Officer
No 10b5-1 planSold 1.6% of holdings ($5.2M position)144,032 shares left1.7x usual sizeFiling
- 6 Form 4 sale Mirati Therapeutics, Inc.No planDec 18, 2023 +101 days
Sold 2,387 shares at $57.50 ($137k)
Christensen Jamie, EVP & Chief Scientific Officer
No 10b5-1 planSold 1.7% of holdings ($8.3M position)141,645 shares left1.4x usual sizeFiling
- 7 Form 4 sale Mirati Therapeutics, Inc.No planJan 4, 2024 +17 days
Sold 1,531 shares at $58.81 ($90k)
Christensen Jamie, EVP & Chief Scientific Officer
No 10b5-1 planSold 1% of holdings ($9.3M position)157,135 shares left0.8x usual sizeFiling
- 8 Form 4 sale Mirati Therapeutics, Inc.No planJan 16, 2024 +12 days
Sold 1,597 shares at $59.02 ($94k)
Christensen Jamie, EVP & Chief Scientific Officer
No 10b5-1 planSold 1% of holdings ($9.3M position)155,927 shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (29)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | Jan 18, 2024 | Mirati Therapeutics, Inc. | EVP & Chief Scientific Officer | Form 4 sale | 1,597 | $94k | 1.0% | No plan | SEC |
| Jan 4, 2024 | Jan 5, 2024 | Mirati Therapeutics, Inc. | EVP & Chief Scientific Officer | Form 4 sale | 1,531 | $90k | 1.0% | No plan | SEC |
| Dec 18, 2023 | Dec 19, 2023 | Mirati Therapeutics, Inc. | EVP & Chief Scientific Officer | Form 4 sale | 2,387 | $137k | 1.7% | No plan | SEC |
| Sep 8, 2023 | Sep 12, 2023 | Mirati Therapeutics, Inc. | EVP & Chief Scientific Officer | Form 4 sale | 2,388 | $85k | 1.6% | No plan | SEC |
| May 24, 2023 | May 24, 2023 | Mirati Therapeutics, Inc. | EVP & Chief Scientific Officer | Form 4 sale | 619 | $28k | 0.5% | No plan | SEC |
| Jan 17, 2023 | Jan 19, 2023 | Mirati Therapeutics, Inc. | EVP, Chief Scientific Officer | Form 4 sale | 2,245 | $95k | 2.2% | Plan not stated | SEC |
| Jan 4, 2023 | Jan 5, 2023 | Mirati Therapeutics, Inc. | EVP, Chief Scientific Officer | Form 4 sale | 1,949 | $91k | 1.9% | Plan not stated | SEC |
| Dec 16, 2022 | Dec 20, 2022 | Mirati Therapeutics, Inc. | EVP, Chief Scientific Officer | Form 4 sale | 2,410 | $104k | 2.3% | Plan not stated | SEC |
| Dec 2, 2022 | Dec 5, 2022 | Mirati Therapeutics, Inc. | EVP, Chief Scientific Officer | Form 4 sale | 1,726 | $156k | 1.6% | Plan not stated | SEC |
| May 23, 2022 | Jun 14, 2022 | Mirati Therapeutics, Inc. | EVP, Chief Scientific Officer | Form 4 sale | 624 | $40k | 0.7% | Plan not stated | SEC |
| Jan 18, 2022 | Jan 18, 2022 | Mirati Therapeutics, Inc. | EVP, Chief Scientific Officer | Form 4 sale | 627 | $76k | 0.7% | Plan not stated | SEC |
| Jan 4, 2022 | Jan 6, 2022 | Mirati Therapeutics, Inc. | EVP, Chief Scientific Officer | Form 4 sale | 1,442 | $213k | 1.8% | Plan not stated | SEC |
| Dec 6, 2021 | Dec 7, 2021 | Mirati Therapeutics, Inc. | EVP, Chief Scientific Officer | Form 4 sale | 1,201 | $157k | 2.0% | Plan not stated | SEC |
| May 24, 2021 | May 25, 2021 | Mirati Therapeutics, Inc. | EVP, Chief Scientific Officer | Form 4 sale | 435 | $67k | 0.8% | Plan not stated | SEC |
| Jan 6, 2021 | Jan 8, 2021 | Mirati Therapeutics, Inc. | EVP, Chief Scientific Officer | Form 4 sale | 1,459 | $307k | 3.0% | Plan not stated | SEC |
| Dec 23, 2019 | Dec 26, 2019 | Mirati Therapeutics, Inc. | EVP, Chief Scientific Officer | Form 4 sale | 6,666 | $833k | 42.1% | Unusual | SEC |
| Jun 27, 2018 | Jun 28, 2018 | Mirati Therapeutics, Inc. | SVP, Chief Scientific Officer | Form 4 sale | 10,207 | $502k | 75.0% | Unusual | SEC |
| Mar 9, 2018 | Apr 26, 2018 | Mirati Therapeutics, Inc. | SVP, Chief Scientific Officer | Form 4 sale | 22,000 | $726k | 88.4% | Unusual | SEC |
| Feb 6, 2018 | Feb 8, 2018 | Mirati Therapeutics, Inc. | SVP, Chief Scientific Officer | Form 4 sale | 23,000 | $690k | 88.9% | Unusual | SEC |
| Jan 26, 2018 | Jan 29, 2018 | Mirati Therapeutics, Inc. | SVP, Chief Scientific Officer | Form 4 sale | 12,500 | $326k | 81.3% | Unusual | SEC |
| Jan 16, 2018 | Jan 18, 2018 | Mirati Therapeutics, Inc. | SVP, Chief Science Officer | Form 4 sale | 10,814 | $292k | 79.0% | Unusual | SEC |
| Jan 11, 2018 | Jan 11, 2018 | Mirati Therapeutics, Inc. | SVP, Chief Science Officer | Form 4 sale | 14,725 | $338k | 83.7% | Unusual | SEC |
| Nov 16, 2017 | Nov 17, 2017 | Mirati Therapeutics, Inc. | SVP, Chief Science Officer | Form 4 sale | 10,275 | $185k | 81.1% | Unusual | SEC |
| Nov 2, 2017 | Nov 3, 2017 | Mirati Therapeutics, Inc. | SVP, Chief Science Officer | Form 4 sale | 7,499 | $105k | 73.7% | Unusual | SEC |
| Oct 4, 2017 | Oct 6, 2017 | Mirati Therapeutics, Inc. | SVP, Chief Science Officer | Form 4 sale | 4,000 | $56k | 60.0% | Unusual | SEC |
| Sep 15, 2017 | Sep 18, 2017 | Mirati Therapeutics, Inc. | SVP, Chief Science Officer | Form 4 sale | 770 | $9k | 22.4% | Plan not stated | SEC |
| May 26, 2015 | May 27, 2015 | Mirati Therapeutics, Inc. | SVP & Chief Scientific Officer | Form 4 sale | 4,750 | $133k | 79.2% | Unusual | SEC |
| Mar 5, 2015 | Mar 6, 2015 | Mirati Therapeutics, Inc. | SVP & Chief Scientific Officer | Form 4 sale | 6,000 | $152k | 82.8% | Unusual | SEC |
| Feb 19, 2015 | Feb 19, 2015 | Mirati Therapeutics, Inc. | SVP & Chief Scientific Officer | Form 4 sale | 4,750 | $108k | 79.2% | Unusual | SEC |